We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+6.94%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$54.2B
AUM Growth
+$30.1B
(+125%)
Cap. Flow
+$28.6B
Cap. Flow
% of AUM
52.81%
Top 10 Holdings %
Top 10 Hldgs %
15.56%
Holding
4,600
New
1,635
Increased
1,281
Reduced
635
Closed
782
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.08B |
| 2 |
Amazon
AMZN
|
+$1B |
| 3 |
Meta Platforms (Facebook)
META
|
+$844M |
| 4 |
Apple
AAPL
|
+$842M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$725M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$192M |
| 2 |
West Pharmaceutical
WST
|
+$107M |
| 3 |
Advanced Micro Devices
AMD
|
+$97.2M |
| 4 |
Bio-Rad Laboratories Class A
BIO
|
+$79.3M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$79.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.77% |
| 2 | Healthcare | 17.47% |
| 3 | Financials | 15.58% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAAS
3226
Maase Inc
MAAS
$7.3B
| $150K | ﹤0.01% |
+377
| New | +$142K |
|
|
FPAY
3227
DELISTED
FlexShopper
FPAY
| $149K | ﹤0.01% |
63,760
+23,443
| +58% | +$60.5K |
|
3228
LSI Industries
LYTS
$868M
| $149K | ﹤0.01% |
21,658
-7,281
| -25% | -$55K |
|
3229
Green Plains
GPRE
$1.15B
| $148K | ﹤0.01% |
+4,291
| New | +$160K |
|
|
BQ
3230
Boqii Holding Ltd
BQ
$6.01M
| $145K | ﹤0.01% |
820
+195
| +31% | +$66.5K |
|
3231
Northern Oil and Gas
NOG
$2.17B
| $145K | ﹤0.01% |
+7,056
| New | +$158K |
|
3232
GrowGeneration
GRWG
$88.9M
| $144K | ﹤0.01% |
11,070
-122,041
| -92% | -$2.34M |
|
|
DXYN
3233
DELISTED
Dixie Group Inc
DXYN
| $144K | ﹤0.01% |
25,167
+5,487
| +28% | +$29.9K |
|
3234
First Bank
FRBA
$475M
| $143K | ﹤0.01% |
9,860
-1,941
| -16% | -$28.8K |
|
3235
CALL
Grab Holdings Warrant
GRABW
$520K
| $143K | ﹤0.01% |
+19,993
| New | +$44.2K |
|
3236
Morningstar
MORN
$7.37B
| $143K | ﹤0.01% |
+417
| New | +$129K |
|
|
NOTV
3237
DELISTED
Inotiv
NOTV
| $143K | ﹤0.01% |
+3,397
| New | +$152K |
|
|
CNCE
3238
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $143K | ﹤0.01% |
45,383
-29,570
| -39% | -$98.4K |
|
3239
Crocs
CROX
$6.72B
| $142K | ﹤0.01% |
1,107
-151,808
| -99% | -$23.4M |
|
3240
EyePoint Inc
EYPT
$1B
| $142K | ﹤0.01% |
+11,608
| New | +$156K |
|
3241
Alaunos Therapeutics
TCRT
$4.57M
| $142K | ﹤0.01% |
871
-2,588
| -75% | -$569K |
|
3242
Aspen Aerogels
ASPN
$362M
| $141K | ﹤0.01% |
+2,846
| New | +$150K |
|
3243
Infosys
INFY
$49.6B
| $140K | ﹤0.01% |
5,545
-47,907
| -90% | -$1.11M |
|
3244
SkyWater Technology
SKYT
$1.53B
| $140K | ﹤0.01% |
+8,661
| New | +$194K |
|
|
TSP
3245
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $140K | ﹤0.01% |
+3,889
| New | +$145K |
|
|
PARAA
3246
DELISTED
Paramount Global Class A
PARAA
| $139K | ﹤0.01% |
+4,205
| New | +$157K |
|
3247
X4 Pharmaceuticals
XFOR
$355M
| $139K | ﹤0.01% |
2,016
+1,175
| +140% | +$149K |
|
3248
Eterna Therapeutics
ERNA
$4.32M
| $138K | ﹤0.01% |
+4
| New | +$218K |
|
3249
Flux Power
FLUX
$11.7M
| $138K | ﹤0.01% |
+32,336
| New | +$172K |
|
3250
Immunome
IMNM
$2.61B
| $138K | ﹤0.01% |
10,654
+2,306
| +28% | +$41.1K |
|
Similar funds
Marshall Wace's Q4 2021 Portfolio in Review
As of Q4 2021, Marshall Wace held 4,600 positions worth $54.2B, up 125% from $24.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Marshall Wace deployed $28.6B of net new capital in Q4 2021, opening 1,635 new positions and adding to 1,281 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Accenture, an estimated $192M trimmed.
- Marshall Wace's largest Q4 2021 buy was State Street SPDR S&P 500 ETF Trust: 1,140,732 shares worth $542M.
- Marshall Wace added most to Microsoft in Q4 2021, an estimated $1.08B increase.
- Marshall Wace's biggest Q4 2021 reduction was Accenture, cutting an estimated $192M.
- Marshall Wace fully exited Sabre in Q4 2021, selling an estimated $44.1M.
- Marshall Wace's ten largest holdings make up 16% of its $54.2B portfolio in Q4 2021.
- Marshall Wace opened 1,635 new positions and closed 782 in Q4 2021.
- Marshall Wace's portfolio value rose 125% quarter-over-quarter to $54.2B.
Based on Marshall Wace's 13F filing for Q4 2021, filed 14 Feb 2022.